|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoffman RM: Clinical practice. Screening
for prostate cancer. N Engl J Med. 365:2013–2019. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sutcliffe S, Nevin RL, Pakpahan R, Elliott
DJ, Cole SR, De Marzo AM, Gaydos CA, Isaacs WB, Nelson WG, Sokoll
LJ, et al: Prostate involvement during sexually transmitted
infections as measured by prostate-specific antigen concentration.
Br J Cancer. 105:602–605. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
de Villiers EM, Wagner D, Schneider A,
Wesch H, Miklaw H, Wahrendorf J, Papendick U and zur Hausen H:
Human papillomavirus infections in women with and without abnormal
cervical cytology. Lancet. 2:703–706. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen AC, Waterboer T, Keleher A, Morrison
B, Jindal S, McMillan D, Nicol D, Gardiner RA, McMillan NA and
Antonsson A: Human papillomavirus in benign prostatic hyperplasia
and prostatic adenocarcinoma patients. Pathol Oncol Res.
17:613–617. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tommasino M: The human papillomavirus
family and its role in carcinogenesis. Semin Cancer Biol. 26:13–21.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Onon TS: History of human papillomavirus,
warts and cancer: What do we know today? Best Pract Res Clin Obstet
Gynaecol. 25:565–574. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Videla S, Darwich L, Cañadas M, Clotet B
and Sirera G: Incidence and clinical management of oral human
papillomavirus infection in men: A series of key short messages.
Expert Rev Anti Infect Ther. 12:947–957. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McNicol PJ and Dodd JG: Detection of human
papillomavirus DNA in prostate gland tissue by using the polymerase
chain reaction amplification assay. J Clin Microbiol. 28:409–412.
1990.PubMed/NCBI
|
|
11
|
Ramezani A, Banifazl M, Eslamifar A and
Aghakhani A: Association between human papillomavirus infection and
risk of prostate cancer. Iranian J Pathol. 1:3–7. 2011.
|
|
12
|
Kuczyk M, Serth J, Machtens S and Jonas U:
Detection of viral HPV 16 DNA in prostate cancer and benign
prostatic hyperplasia by quantitative PCR-directed analysis.
Prostate Cancer Prostatic Dis. 3 Suppl 1:S232000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kuczyk M, Serth J, Machtens S and Jonas U:
Detection viral HPV 16 DNA in prostate cancer and benign prostatic
hyperplasia by quantitative PCR-directed analysis. Prostate Cancer
Prostatic Dis. 3 Suppl 1:S232000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McNicol PJ and Dodd JG: Detection of
papillomavirus DNA in human prostatic tissue by Southern blot
analysis. Can J Microbiol. 36:359–362. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou Q, Luo ML, Li H, Li M and Zhou JG:
Coffee consumption and risk of endometrial cancer: A dose-response
meta-analysis of prospective cohort studies. Sci Rep. 5:134102015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
DerSimonian R and Kacker R: Random-effects
model for meta-analysis of clinical trials: An update. Contemp Clin
Trials. 28:105–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
20
|
Begg CB and Mazumdar M: Operating
characteristics of a rank correlation test for publication bias.
Biometrics. 50:1088–1101. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Egger M, Smith G Davey, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Serth J, Panitz F, Paeslack U, Kuczyk MA
and Jonas U: Increased levels of human papillomavirus type 16 DNA
in a subset of prostate cancers. Cancer Res. 59:823–825.
1999.PubMed/NCBI
|
|
23
|
McNicol PJ and Dodd JG: High prevalence of
human papillomavirus in prostate tissues. J Urol. 145:850–853.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Smelov V, Ouburg S, Pleijster J, Smelova
N, Van Moorselaar RJA and Morre SA: Detection of Hr-Hpv Dna in the
prostate of men with prostate cancer. Eur Urol Suppl. 8:2612009.
View Article : Google Scholar
|
|
25
|
Balis V, Sourvinos G, Soulitzis N,
Giannikaki E, SofraS F and Spandidos DA: Prevalence of BK virus and
human papillomavirus in human prostate cancer. Int J Biol Marker.
22:245–251. 2007. View Article : Google Scholar
|
|
26
|
Saad F, Gu K, Jean-Baptiste J, Gauthier J
and MesMasson AM: Absence of human papillomavirus sequences in
early stage prostate cancer. Can J Urol. 6:834–838. 1999.PubMed/NCBI
|
|
27
|
Sarkar FH, Sakr WA, Li YW, Sreepathi P and
Crissman JD: Detection of human papillomavirus (HPV) DNA in human
prostatic tissues by polymerase chain reaction (PCR). Prostate.
22:171–180. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Serfling U, Ciancio G, Zhu WY, Leonardi C
and Penneys NS: Human papillomavirus and herpes virus DNA are not
detected in benign and malignant prostatic tissue using the
polymerase chain reaction. J Urol. 148:192–194. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Effert PJ, Frye RA, Neubauer A, Liu ET and
Walther PJ: Human papillomavirus types 16 and 18 are not involved
in human prostate carcinogenesis: Analysis of archival human
prostate cancer specimens by differential polymerase chain
reaction. J Urol. 147:192–196. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tu H, Jacobs SC, Mergner WJ and Kyprianou
N: Rare incidence of human papillomavirus types 16 and 18 in
primary and metastatic human prostate cancer. Urology. 44:726–731.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Martinez-Fierro ML, Leach RJ, Gomez-Guerra
LS, Garza-Guajardo R, Johnson-Pais T, Beuten J, Morales-Rodriguez
IB, Hernandez-Ordoñez MA, Calderon-Cardenas G, Ortiz-Lopez R, et
al: Identification of viral infections in the prostate and
evaluation of their association with cancer. BMC Cancer.
10:3262010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Silvestre RV, Leal MF, Demachki S, Nahum
MC, Bernardes JG, Rabenhorst SH, Mde A Smith, Mello WA, Guimarães
AC and Burbano RR: Low frequency of human papillomavirus detection
in prostate tissue from individuals from Northern Brazil. Mem Inst
Oswaldo Cruz. 104:665–667. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sinclair AL, Nouri AM, Oliver RT, Sexton C
and Dalgleish AG: Bladder and prostate cancer screening for human
papillomavirus by polymerase chain reaction: Conflicting results
using different annealing temperatures. Br J Biomed Sci.
50:350–354. 1993.PubMed/NCBI
|
|
34
|
Maitland NJ, Macintosh CA, Schmitz C and
Lang SH: Immortalization of human prostate cells with the human
papillomavirus type 16 E6 gene. Methods Mol Med. 88:275–285.
2004.PubMed/NCBI
|
|
35
|
Smelov V, Gorelov A, Pleijster J,
Savicheva A, Pena S and Morre S: The relevance of HPV infection in
men with chronic inflammation of the prostate. Eur Urol Suppl.
6:712007. View Article : Google Scholar
|
|
36
|
Terris MK and Peehl DM: Human
papillomavirus detection by polymerase chain reaction in benign and
malignant prostate tissue is dependent on the primer set utilized.
Urology. 50:150–156. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pascale M, Pracella D, Barbazza R,
Marongiu B, Roggero E, Bonin S and Stanta G: Is human
papillomavirus associated with prostate cancer survival? Dis
Markers. 35:607–613. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Singh N, Hussain S, Kakkar N, Singh SK,
Sobti RC and Bharadwaj M: Implication of high risk Human
papillomavirus HR-HPV infection in prostate cancer in Indian
population-A pioneering case-control analysis. Sci Rep. 5:78222015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Michopoulou V, Derdas SP, Symvoulakis E,
Mourmouras N, Nomikos A, Delakas D, Sourvinos G and Spandidos DA:
Detection of human papillomavirus (HPV) DNA prevalence and p53
codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek
group of patients. Tumour Biol. 35:12765–12773. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ghasemian E, Monavari SH, Irajian GR,
Nodoshan MR Jalali, Roudsari RV and Yahyapour Y: Evaluation of
human papillomavirus infections in prostatic disease: A
cross-sectional study in Iran. Asian Pac J Cancer Prev.
14:3305–3308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Whitaker NJ, Glenn WK, Sahrudin A, Orde
MM, Delprado W and Lawson JS: Human papillomavirus and Epstein Barr
virus in prostate cancer: Koilocytes indicate potential oncogenic
influences of human papillomavirus in prostate cancer. Prostate.
73:236–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tachezy R, Hrbacek J, Heracek J, Salakova
M, Smahelova J, Ludvikova V, Svec A, Urban M and Hamsikova E: HPV
persistence and its oncogenic role in prostate tumors. J Med Virol.
84:1636–1645. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Salehi Z and Hadavi M: Analysis of the
codon 72 polymorphism of TP53 and human papillomavirus infection in
Iranian patients with prostate cancer. J Med Virol. 84:1423–1427.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Aghakhani A, Hamkar R, Parvin M, Ghavami
N, Nadri M, Pakfetrat A, Banifazl M, Eslamifar A, Izadi N, Jam S
and Ramezani A: The role of human papillomavirus infection in
prostate carcinoma. Scand Int J Infect Dis. 43:64–69. 2011.
View Article : Google Scholar
|
|
45
|
Gazzaz FS and Mosli HA: Lack of detection
of human papillomavirus infection by hybridization test in
prostatic biopsies. Saudi Med J. 30:633–637. 2009.PubMed/NCBI
|
|
46
|
Leiros GJ, Galliano SR, Sember ME, Kahn T,
Schwarz E and Eiguchi K: Detection of human papillomavirus DNA and
p53 codon 72 polymorphism in prostate carcinomas of patients from
Argentina. BMC Urol. 5:152005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Carozzi F, Lombardi FC, Zendron P,
Confortini M, Sani C, Bisanzi S, Pontenani G and Ciatto S:
Association of human papillomavirus with prostate cancer: Analysis
of a consecutive series of prostate biopsies. Int J Biol Marker.
19:257–261. 2004. View Article : Google Scholar
|
|
48
|
Noda T, Sasagawa T, Dong Y, Fuse H, Namiki
M and Inoue M: Detection of human papillomavirus (HPV) DNA in
archival specimens of benign prostatic hyperplasia and prostatic
cancer using a highly sensitive nested PCR method. Urol Res.
26:165–169. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Strickler HD, Burk R, Shah K, Viscidi R,
Jackson A, Pizza G, Bertoni F, Schiller JT, Manns A, Metcalf R, et
al: A multifaceted study of human papillomavirus and prostate
carcinoma. Cancer. 82:1118–1125. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Anderson M, Handley J, Hopwood L, Murant
S, Stower M and Maitland NJ: Analysis of prostate tissue DNA for
the presence of human papillomavirus by polymerase chain reaction,
cloning, and automated sequencing. J Med Virol. 52:8–13. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Suzuki H, Komiya A, Aida S, Ito H, Yatani
R and Shimazaki J: Detection of human papillomavirus DNA and p53
gene mutations in human prostate cancer. Prostate. 28:318–324.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wideroff L, Schottenfeld D, Carey TE,
Beals T, Fu G, Sakr W, Sarkar F, Schork A, Grossman HB and Shaw MW:
Human papillomavirus DNA in malignant and hyperplastic prostate
tissue of black and white males. Prostate. 28:117–123. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Moyret-Lalle C, Marcais C, Jacquemier J,
Moles JP, Daver A, Soret JY, Jeanteur P, Ozturk M and Theillet C:
ras, p53 and HPV status in benign and malignant prostate tumors.
Int J Cancer. 64:124–129. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Dodd JG, Paraskevas M and McNicol PJ:
Detection of human papillomavirus 16 transcription in human
prostate tissue. J Urol. 149:400–402. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Rotola A, Monini P, Di Luca D, Savioli A,
Simone R, Secchiero P, Reggiani A and Cassai E: Presence and
physical state of HPV DNA in prostate and urinary-tract tissues.
Int J Cancer. 52:359–365. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Anwar K, Nakakuki K, Shiraishi T, Naiki H,
Yatani R and Inuzuka M: Presence of ras oncogene mutations and
human papillomavirus DNA in human prostate carcinomas. Cancer Res.
52:5991–5996. 1992.PubMed/NCBI
|
|
57
|
Ibrahim GK, Gravitt PE, Dittrich KL,
Ibrahim SN, Melhus O, Anderson SM and Robertson CN: Detection of
human papillomavirus in the prostate by polymerase chain reaction
and in situ hybridization. J Urol. 148:1822–1826. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Masood S, Rhatigan RM, Powell S, Thompson
J and Rodenroth N: Human papillomavirus in prostatic cancer: No
evidence found by in situ DNA hybridization. South Med J.
84:235–236. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Colón-López V, Ortiz AP, Del Toro-Mejías
LM, García H, Clatts MC and Palefsky J: Awareness and knowledge of
human papillomavirus (HPV) infection among high-risk men of
Hispanic origin attending a sexually transmitted infection (STI)
clinic. BMC Infect Dis. 12:3462012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Baker R, Dauner JG, Rodriguez AC, Williams
MC, Kemp TJ, Hildesheim A and Pinto LA: Increased plasma levels of
adipokines and inflammatory markers in older women with persistent
HPV infection. Cytokine. 53:282–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Mendoza N, Hernandez PO and Tyring SK: HPV
vaccine update: New indications and controversies. Skin Therapy
Lett. 16:1–3. 2011.PubMed/NCBI
|
|
63
|
Hopkins TG and Wood N: Female human
papillomavirus (HPV) vaccination: Global uptake and the impact of
attitudes. Vaccine. 31:1673–1679. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Colón-López V, Ortiz AP and Palefsky J:
Burden of human papillomavirus infection and related comorbidities
in men: Implications for research, disease prevention and health
promotion among Hispanic men. P R Health Sci J. 29:232–240.
2010.PubMed/NCBI
|
|
65
|
de Lima Rocha MG, Faria FL, Goncalves L,
Mdo C Souza, Fernandes PÁ and Fernandes AP: Prevalence of DNA-HPV
in male sexual partners of HPV-infected women and concordance of
viral types in infected couples. PLoS One. 7:e409882012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Taylor ML, Mainous AG III and Wells BJ:
Prostate cancer and sexually transmitted diseases: A meta-analysis.
Fam Med. 37:506–512. 2005.PubMed/NCBI
|
|
67
|
Jayaprakash V, Reid M, Hatton E, Merzianu
M, Rigual N, Marshall J, Gill S, Frustino J, Wilding G, Loree T, et
al: Human papillomavirus types 16 and 18 in epithelial dysplasia of
oral cavity and oropharynx: A meta-analysis, 1985–2010. Oral Oncol.
47:1048–1054. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Li N, Bi X, Zhang Y, Zhao P, Zheng T and
Dai M: Human papillomavirus infection and sporadic breast carcinoma
risk: A meta-analysis. Breast Cancer Res Treat. 126:515–520. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
O'Rorke MA, Ellison MV, Murray LJ, Moran
M, James J and Anderson LA: Human papillomavirus related head and
neck cancer survival: A systematic review and meta-analysis. Oral
Oncol. 48:1191–1201. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Li N, Yang L, Zhang Y, Zhao P, Zheng T and
Dai M: Human papillomavirus infection and bladder cancer risk: A
meta-analysis. J Infect Dis. 204:217–223. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Grulich AE and Vajdic CM: The epidemiology
of cancers in human immunodeficiency virus infection and after
organ transplantation. Semin Oncol. 42:247–257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Vieira VC, Leonard B, White EA, Starrett
GJ, Temiz NA, Lorenz LD, Lee D, Soares MA, Lambert PF, Howley PM
and Harris RS: Human papillomavirus E6 triggers upregulation of the
antiviral and cancer genomic DNA deaminase APOBEC3B. MBio. 5(pii):
e02234–e14. 2014.PubMed/NCBI
|
|
73
|
Gwak M, Choi YJ, Yoo NJ and Lee S:
Expression of DNA cytosine deaminase APOBEC3 proteins, a potential
source for producing mutations, in gastric, colorectal and prostate
cancers. Tumori. 100:112e–117e. 2014.PubMed/NCBI
|
|
74
|
Cantalupo PG, Katz JP and Pipas JM: HeLa
nucleic acid contamination in the cancer genome atlas leads to the
misidentification of human papillomavirus 18. J Virol.
89:4051–4057. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Lin Y, Mao Q, Zheng X, Yang K, Chen H,
Zhou C and Xie L: Human papillomavirus 16 or 18 infection and
prostate cancer risk: A meta-analysis. Ir J Med Sci. 180:497–503.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Simen-Kapeu A, Surcel HM, Koskela P,
Pukkala E and Lehtinen M: Lack of association between human
papillomavirus type 16 and 18 infections and female lung cancer.
Cancer Epidemiol Biomarkers Prev. 19:1879–1881. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bae JM: Human papillomavirus 16 infection
as a potential risk factor of prostate cancer: An adaptive
meta-analysis. Epidemiol Health. 37:e20150052015. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Hrbacek J, Urban M, Hamsikova E, Tachezy R
and Heracek J: Thirty years of research on infection and prostate
cancer: No conclusive evidence for a link. A systematic review.
Urol Oncol. 31:951–965. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Bruni L, Diaz M, Castellsagué X, Ferrer E,
Bosch FX and de Sanjosé S: Cervical human papillomavirus prevalence
in 5 continents: Meta-analysis of 1 million women with normal
cytological findings. J Infect Dis. 202:1789–1799. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Svahn MF, Faber MT, Christensen J, Norrild
B and Kjaer SK: Prevalence of human papillomavirus in epithelial
ovarian cancer tissue. A meta-analysis of observational studies.
Acta Obstet Gynecol Scand. 93:6–19. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Abreu AL, Souza RP, Gimenes F and
Consolaro ME: A review of methods for detect human papillomavirus
infection. Virol J. 9:2622012. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Kalmár A, Péterfia B, Wichmann B, Patai
ÁV, Barták BK, Nagy ZB, Furi I, Tulassay Z and Molnár B: Comparison
of automated and manual DNA isolation methods for DNA methylation
analysis of biopsy, fresh frozen and formalin-fixed,
paraffin-embedded colorectal cancer samples. J Lab Autom.
20:642–651. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Mori S, Nakao S, Kukimoto I,
Kusumoto-Matsuo R, Kondo K and Kanda T: Biased amplification of
human papillomavirus DNA in specimens containing multiple human
papillomavirus types by PCR with consensus primers. Cancer Sci.
102:1223–1227. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Strauss S, Sastry P, Sonnex C, Edwards S
and Gray J: Contamination of environmental surfaces by genital
human papillomaviruses. Sex Transm Infect. 78:135–138. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Ferenczy A, Bergeron C and Richart RM:
Human papillomavirus DNA in fomites on objects used for the
management of patients with genital human papillomavirus
infections. Obstet Gynecol. 74:950–954. 1989.PubMed/NCBI
|
|
86
|
Iwasaka T, Hayashi Y, Yokoyama M, Hara K,
Matsuo N and Sugimori H: ‘Hit and run’ oncogenesis by human
papillomavirus type 18 DNA. Acta Obstet Gynecol Scand. 71:219–223.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Thorpe A and Neal D: Benign prostate
hyperplasia. Lancet. 361:1359–1367. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Boddy JL, Pike DJ and Malone PR: A
seven-year follow-up of men following a benign prostate biopsy. Eur
Urol. 44:17–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Brossner C, Madersbacher S, de Mare P,
Ponholzer A, Al-Ali B and Rauchenwald M: Follow-up of men obtaining
a six-core versus a ten-core benign prostate biopsy 7 years
previously. World J Urol. 23:419–421. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Durkan GC and Greene DR: Elevated serum
prostate specific antigen levels in conjunction with an initial
prostatic biopsy negative for carcinoma: Who should undergo a
repeat biopsy? BJU Int. 83:34–38. 1999. View Article : Google Scholar : PubMed/NCBI
|
